30792533 |
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
Serrano, C,
Mariño-Enríquez, A,
Tao, DL,
Ketzer, J,
Eilers, G,
Zhu, M,
Yu, C,
Mannan, AM,
Rubin, BP,
Demetri, GD,
Raut, CP,
Presnell, A,
McKinley, A,
Heinrich, MC,
Czaplinski, JT,
Sicinska, E,
Bauer, S,
George, S,
Fletcher, JA
|
Br. J. Cancer |
2019 |
25239608 |
Ponatinib inhibits polyclonal drug-resistant KIT oncoproteins and shows therapeutic potential in heavily pretreated gastrointestinal stromal tumor (GIST) patients
Garner, AP,
Gozgit, JM,
Anjum, R,
Vodala, S,
Schrock, A,
Zhou, T,
Serrano, C,
Eilers, G,
Zhu, M,
Ketzer, J,
Wardwell, S,
Ning, Y,
Song, Y,
Kohlmann, A,
Wang, F,
Clackson, T,
Heinrich, MC,
Fletcher, JA,
Bauer, S,
Rivera, VM
|
Clin. Cancer Res. |
2014 |